ChartRow logo
Data provided bySource: Twelve Data
CORT
$70.07+1.23%
as of close, Nov 17, 2026
☾ AH $70.07 +1.23%
PeersHALOALNYTWSTKRYSHLPCVX
Share this page

Corcept Therapeutics Incorporated total returns by year (including dividends)

As of market close, Nov 17, 2026

Corcept Therapeutics Incorporated annual returns by year
YearTotal return
2026YTD
+101.4%
2025
-30.9%
2024
+55.1%
2023
+59.9%
2022
+2.6%
2021
-24.3%
2020
+116.2%
2019
-9.4%
2018
-26.0%
2017
+148.8%
2016
+45.8%
2015
+66.0%
2014
-6.5%
2013
+124.5%
2012
-58.2%
2011
-11.4%
2010
+38.8%
2009
+172.5%
2008
-67.0%
2007
+151.2%
2006
-66.3%
2005
-41.6%
2004since Apr 14
-48.9%
Annualized
+8.2%
2005–2026
Average year
+30.5%
21 full years
Best year
+172.5%
2009
Worst year
-67.0%
2008
Positive years
11/21
52% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on CORT. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Corcept Therapeutics Incorporated's average annual return?
Since 2005, Corcept Therapeutics Incorporated (CORT) has returned about 8.2% a year (the compound annual growth rate) and an average calendar-year return of 30.5%.
What were Corcept Therapeutics Incorporated's best and worst years?
Over 2005–2026, the best year was 2009 (+172.5%) and the worst was 2008 (-67.0%).
How often is Corcept Therapeutics Incorporated up in a year?
11 of the 21 full years since 2005 were positive — about 52% of the time.

More on Corcept Therapeutics Incorporated